You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 18, May 9, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thiazide Use and Reduced Sodium Intake for Prevention of Osteoporosis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: I was disappointed that, in the National Institutes of Health (NIH) Consensus Statement on osteoporosis,1 no mention was made of data showing that thiazide diuretics prevent the disease. At usual antihypertensive doses, thiazides have been shown to preserve bone mineralization at the wrist, elbow, and heel,2 and the hip and spine.3 More importantly, the incidence of hip fracture is reduced by 30% in those patients taking thiazides.4-5

Thiazides are inexpensive and safe, but no great profits are made from their sales. Instead, physicians are bombarded with data about bisphosphonates, selective estrogen-receptor modulators, and calcitonin, which are under patent and are expensive. The studies on thiazides for the prevention of osteoporosis are equally compelling and deserve more attention.

Robert S. Bobrow, MD
Bay Shore, NY

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795. FREE FULL TEXT
2. Wasnich RD, Benfante RJ, Yano K, Heilburn L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med. 1983;309:344-346. ABSTRACT
3. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:516-526. FREE FULL TEXT
4. LaCroix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med. 1990;322:286-290. ABSTRACT
5. Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture: results from the Framingham Study. JAMA. 1991;265:370-373. FREE FULL TEXT


To the Editor: The recent NIH Consensus Statement on osteoporosis1 acknowledges the risk of low bone mineral density for osteoporosis in all populations . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
JAMA. 2001;285(6):785-795.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.